Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Dexmedetomidine Premedication on Sleep Disturbance After General Anaesthesia
NCT06281561Phase 3Not yet recruiting
- Sponsor
- First Affiliated Hospital of Xiamen University
- Start
- May 2024
- Primary completion
- Nov 2024
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of dexmedetomidine in Postoperative sleep disturbance (PSD), sponsored by First Affiliated Hospital of Xiamen University. Planned start May 2024; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Postoperative sleep disturbance (PSD)
Beyond the preview
Go deeper on NCT06281561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06281561.